Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Clover at Risk on Rollback of Trump Medicare Program (Correct)

Feb. 18, 2022, 1:07 PM

A potential rollback of a Trump administration Medicare program could threaten a handful of recently listed stocks from the past two years including Clover Health Investments Corp.

Clover, which went public in a blank-check merger backed by Chamath Palihapitiya, has already seen its stock drop 90% from a June peak. But the stock could take another leg downward if a program known as direct contracting -- a payment model that allows private companies to take part in Medicare -- is ended or scaled back, as it accounts for roughly 60% of its sales, according to Citigroup.

Clover is one ...